Huateng Pharmaceutical, a global supplier of Pharmaceutical intermediates, offers Carfilzomib intermediate  Boc-HPh-Leu-Phe-Ome (CAS No.: 868539-96-2) for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation.

Application: An intermediate of Carfilzomib (C183460) which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.